Ownership history in Cornerstone Planning Group LLC · 9 quarters on record
This page tracks every 13F SEC filing in which Cornerstone Planning Group LLC reported a position in ACURX PHARMACEUTICALS IN (ACXP). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | ADDED | 167 | +100 | +149.3% | 0.00% | $433 | $2.49 |
| 2025 Q3 | REDUCED | 67 | -100 | -59.9% | 0.00% | $5K | $4.29 |
| 2025 Q2 | REDUCED | 167 | -3,177 | -95.0% | 0.00% | $850 | $10.22 |
| 2025 Q1 | UNCHANGED | 3,344 | — | 0% | 0.00% | $1K | $7.80 |
| 2024 Q4 | UNCHANGED | 3,344 | — | 0% | 0.00% | $3K | $16.28 |
| 2024 Q3 | UNCHANGED | 3,344 | — | 0% | 0.00% | $6K | $38.00 |
| 2024 Q2 | UNCHANGED | 3,344 | — | 0% | 0.00% | $6K | $45.00 |
| 2024 Q1 | UNCHANGED | 3,344 | — | 0% | 0.00% | $7K | $49.00 |
| 2023 Q4 | INITIATED | 3,344 | — | — | 0.00% | $13K | — |
As of 2025 Q4 — sorted by position size